Get the Full Story, Without the Noise.
Published loading...Updated

The CRISPR companies are not OK

Summary by STAT
Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR is hard to do profitably.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

STAT broke the news in Boston, United States on Thursday, February 6, 2025.
Sources are mostly out of (0)